A synthetic peptide for use as a blocking control in assays to test for specificity of FANCA antibody, Alternative Names: FANCA control peptide, FANCA antibody Blocking Peptide, Anti-FANCA Blocking Peptide, Fanconi Anemia Complementation Group A Blocking Peptide, FA Blocking Peptide, FA-H Blocking Peptide, FA1 Blocking Peptide, FAA Blocking Peptide, FACA Blocking Peptide, FAH Blocking Peptide, FANCH Blocking Peptide, MGC75158 Blocking Peptide
FANCA
Reaktivität: Human, Maus, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
FANCA
(Fanconi Anemia Group A Protein (FANCA))
Hintergrund
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM and FANCN. The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.